NDC 76961-101

Rolvedon

Eflapegrastim-xnst

Rolvedon is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Spectrum Pharmaceuticals, Inc.. The primary component is Eflapegrastim.

• Product ID: 76961-101_e9602b05-7b39-2b6a-e053-2995a90a78ee
• NDC: 76961-101
• Product Type: Human Prescription Drug
• Proprietary Name: Rolvedon
• Generic Name: Eflapegrastim-xnst
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2022-09-26
• Marketing Category: BLA /
• Application Number: BLA761148
• Labeler Name: Spectrum Pharmaceuticals, Inc.
• Substance Name: EFLAPEGRASTIM
• Active Ingredient Strength: 13 mg/.6mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 76961-101-01

.6 mL in 1 SYRINGE, GLASS (76961-101-01)

• Marketing Start Date: 2022-09-26
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details